Company
IpiNovyx Bio
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
IpiNovyx Bio develops next-generation, ultra-selective proteasome inhibitors for oncology and autoimmune disease applications.
Loading relationship preview